Avila Guillermo, Aguilar Citlalli I, Ramos-Mondragón Roberto
Departamento de Bioquímica, Cinvestav-IPN, AP 14-740, México, DF 07000, México.
J Physiol. 2007 Oct 1;584(Pt 1):47-57. doi: 10.1113/jphysiol.2007.137687. Epub 2007 Jul 26.
We investigated modulation of excitation-contraction (EC) coupling by calcitonin gene-related peptide (CGRP), which is released by motorneurons during neuromuscular transmission. Mouse skeletal myotubes were cultured either under control conditions or in the presence of 100 nm CGRP ( approximately 4-72 h). T- and L-type Ca(2+) currents, immobilization resistant charge movement, and intracellular Ca(2+) transients were characterized in whole-cell patch-clamp experiments. CGRP treatment increased the amplitude of voltage-gated Ca(2+) release ((DeltaF/F)(max)) approximately 75-350% and moderately increased both maximal L-current conductance (G(max)) and charge movement (Q(max)). In contrast, CGRP treatment did not affect their corresponding voltage dependence of activation (V(1/2) and k) or T-current density. CGRP treatment enhanced voltage-gated Ca(2+) release in approximately 4 h, whereas the effect on L-channel magnitude took longer to develop ( approximately 24 h), suggesting that short-term potentiation of EC coupling may lead to subsequent long-term up-regulation of DHPR expression. CGRP treatment also drastically increased caffeine-induced Ca(2+) release in approximately 4 h ( approximately 400%). Thus, short-term potentiation of EC coupling is due to an increase in sarcoplasmic reticulum Ca(2+) content. Both application of a phosphodiesterase inhibitor (papaverine) and a membrane-permeant cAMP analogue (Db-cAMP) produced a similar potentiation of EC coupling. Conversely, this potentiation was prevented by pretreatment with either CGRP1 receptor antagonist (CGRP(8-37)) or a PKA inhibitor (H-89). Thus, CGRP acts through CGRP1 receptors and the cAMP/PKA signalling pathway to enhance voltage-gated Ca(2+) release. Effects of CGRP on both EC coupling and L-channels were attenuated at later times during myotube differentiation. Therefore, we conclude that CGRP accelerates maturation of EC coupling.
我们研究了降钙素基因相关肽(CGRP)对兴奋-收缩(EC)偶联的调节作用,CGRP是运动神经元在神经肌肉传递过程中释放的物质。将小鼠骨骼肌肌管培养于对照条件下或100 nM CGRP存在的环境中(约4 - 72小时)。在全细胞膜片钳实验中对T型和L型Ca(2+)电流、抗固定电荷移动以及细胞内Ca(2+)瞬变进行了表征。CGRP处理使电压门控Ca(2+)释放的幅度((DeltaF/F)(max))增加了约75 - 350%,并适度增加了最大L电流电导(G(max))和电荷移动(Q(max))。相比之下,CGRP处理不影响它们相应的激活电压依赖性(V(1/2)和k)或T电流密度。CGRP处理在约4小时内增强了电压门控Ca(2+)释放,而对L通道大小的影响则需要更长时间才能显现(约24小时),这表明EC偶联的短期增强可能导致随后二氢吡啶受体(DHPR)表达的长期上调。CGRP处理在约4小时内还使咖啡因诱导的Ca(2+)释放大幅增加(约400%)。因此,EC偶联的短期增强是由于肌浆网Ca(2+)含量增加所致。应用磷酸二酯酶抑制剂(罂粟碱)和膜通透性cAMP类似物(双丁酰环磷腺苷,Db-cAMP)均产生了类似的EC偶联增强作用。相反,用CGRP1受体拮抗剂(CGRP(8 - 37))或蛋白激酶A(PKA)抑制剂(H - 89)预处理可阻止这种增强作用。因此,CGRP通过CGRP1受体和cAMP/PKA信号通路增强电压门控Ca(2+)释放。在肌管分化后期,CGRP对EC偶联和L通道的作用均减弱。因此,我们得出结论,CGRP加速了EC偶联的成熟。